Anifrolumab (Saphnelo) March 6, 2024

March 6, 2024 – Lupus Canada is pleased to share that Saphnelo has been listed in Nova Scotia effective March 1, 2024.

The public notice and listing criteria will appear on the Nova Scotia Pharmacare Programs website when the March Bulletin is posted.

Lupus Blog Articles: Lupus lorem ipsum dolor sit amet est requiem deste natur.

Lupus Canada Impact Report 2025 | Advocacy, Awareness & Research Outcomes

Read

Mental Health and Lupus: A Global Perspective

Read

Biogen Lupus Research | New Treatments in Development

Read